相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis
Xianhua Gui et al.
RHEUMATOLOGY (2021)
Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
Muhan Zheng et al.
RHEUMATOLOGY AND THERAPY (2021)
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
Muriel Elhai et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Increases in tumor markers are associated with primary Sjogren's syndrome-associated interstitial lung disease
Lei Shi et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
Jeong Seok Lee et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
Fabiola Atzeni et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?
Gokhan Sargin et al.
ARCHIVES OF RHEUMATOLOGY (2018)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
CHEST (2016)
Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study
Ekin Oktay Oguz et al.
CLINICAL RHEUMATOLOGY (2016)
YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma
Sunisa Thongsom et al.
TUMOR BIOLOGY (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers
Tracy J. Doyle et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients
Inge M. Vercauteren et al.
EXPERIMENTAL LUNG RESEARCH (2015)
Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma
Anne K. Mylin et al.
LEUKEMIA & LYMPHOMA (2015)
Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias
Nicoline M. Korthagen et al.
LUNG (2014)
Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers
Huaping Dai et al.
RESPIROLOGY (2014)
Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients
Stefania Celeste et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Interstitial lung disease in connective tissue disorders
Aryeh Fischer et al.
LANCET (2012)
Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis
Tim Bongartz et al.
ARTHRITIS AND RHEUMATISM (2010)
Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma
Faye N. Hant et al.
JOURNAL OF RHEUMATOLOGY (2009)
Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
H Ohnishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)